Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 16

1.

Intraoperative radiation therapy reduces local recurrence rates in patients with microscopically involved circumferential resection margins after resection of locally advanced rectal cancer.

Alberda WJ, Verhoef C, Nuyttens JJ, van Meerten E, Rothbarth J, de Wilt JH, Burger JW.

Int J Radiat Oncol Biol Phys. 2014 Apr 1;88(5):1032-40. doi: 10.1016/j.ijrobp.2014.01.014.

PMID:
24661656
[PubMed - indexed for MEDLINE]
2.

Outcome in patients with resectable locally recurrent rectal cancer after total mesorectal excision with and without previous neoadjuvant radiotherapy for the primary rectal tumor.

Alberda WJ, Verhoef C, Nuyttens JJ, Rothbarth J, van Meerten E, de Wilt JH, Burger JW.

Ann Surg Oncol. 2014 Feb;21(2):520-6. doi: 10.1245/s10434-013-3306-x. Epub 2013 Oct 12.

PMID:
24121879
[PubMed - indexed for MEDLINE]
3.

The CARTS study: Chemoradiation therapy for rectal cancer in the distal rectum followed by organ-sparing transanal endoscopic microsurgery.

Bökkerink GM, de Graaf EJ, Punt CJ, Nagtegaal ID, Rütten H, Nuyttens JJ, van Meerten E, Doornebosch PG, Tanis PJ, Derksen EJ, Dwarkasing RS, Marijnen CA, Cats A, Tollenaar RA, de Hingh IH, Rutten HJ, van der Schelling GP, Ten Tije AJ, Leijtens JW, Lammering G, Beets GL, Aufenacker TJ, Pronk A, Manusama ER, Hoff C, Bremers AJ, Verhoef C, de Wilt JH.

BMC Surg. 2011 Dec 15;11:34. doi: 10.1186/1471-2482-11-34.

PMID:
22171697
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Chemoradiation for advanced hypopharyngeal carcinoma: a retrospective study on efficacy, morbidity and quality of life.

Keereweer S, Kerrebijn JD, Al-Mamgani A, Sewnaik A, Baatenburg de Jong RJ, van Meerten E.

Eur Arch Otorhinolaryngol. 2012 Mar;269(3):939-46. doi: 10.1007/s00405-011-1694-8. Epub 2011 Jul 8.

PMID:
21739092
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Effect of omeprazole on the pharmacokinetics and toxicities of irinotecan in cancer patients: a prospective cross-over drug-drug interaction study.

van der Bol JM, Loos WJ, de Jong FA, van Meerten E, Konings IR, Lam MH, de Bruijn P, Wiemer EA, Verweij J, Mathijssen RH.

Eur J Cancer. 2011 Apr;47(6):831-8. doi: 10.1016/j.ejca.2010.11.030. Epub 2011 Jan 6.

PMID:
21216137
[PubMed - indexed for MEDLINE]
Free Article
6.

Combined therapy for thyroid squamous cell carcinoma.

De Vos FY, Sewnaik A, de Wilt JH, Smid EJ, den Bakker MA, van Meerten E.

Head Neck. 2012 Jan;34(1):131-4. doi: 10.1002/hed.21484. Epub 2010 Jul 22.

PMID:
20652981
[PubMed - indexed for MEDLINE]
7.

Pathological analysis after neoadjuvant chemoradiotherapy for esophageal carcinoma: the Rotterdam experience.

van Meerten E, van der Gaast A, Tilanus HW, Poley JW, Muller K, van Dekken H.

J Surg Oncol. 2009 Jul 1;100(1):32-7. doi: 10.1002/jso.21295.

PMID:
19402081
[PubMed - indexed for MEDLINE]
8.

[Chemotherapy during clozapine treatment. Increased risk of agranulocytosis?].

van Gool AR, van der Velden MT, Oosten AW, van Meerten E, Verhoeven WM, Loonen AJ.

Tijdschr Psychiatr. 2008;50(10):673-8. Dutch.

PMID:
18951346
[PubMed - indexed for MEDLINE]
Free Article
9.

Quality of life during neoadjuvant treatment and after surgery for resectable esophageal carcinoma.

van Meerten E, van der Gaast A, Looman CW, Tilanus HW, Muller K, Essink-Bot ML.

Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):160-6. doi: 10.1016/j.ijrobp.2007.09.038. Epub 2007 Dec 31.

PMID:
18164846
[PubMed - indexed for MEDLINE]
10.

First-line treatment with oxaliplatin and capecitabine in patients with advanced or metastatic oesophageal cancer: a phase II study.

van Meerten E, Eskens FA, van Gameren EC, Doorn L, van der Gaast A.

Br J Cancer. 2007 May 7;96(9):1348-52. Epub 2007 Apr 17.

PMID:
17437008
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Neoadjuvant concurrent chemoradiation with weekly paclitaxel and carboplatin for patients with oesophageal cancer: a phase II study.

van Meerten E, Muller K, Tilanus HW, Siersema PD, Eijkenboom WM, van Dekken H, Tran TC, van der Gaast A.

Br J Cancer. 2006 May 22;94(10):1389-94.

PMID:
16670722
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Systemic treatment for oesophageal cancer.

van Meerten E, van der Gaast A.

Eur J Cancer. 2005 Mar;41(5):664-72. Epub 2005 Jan 8. Review.

PMID:
15763640
[PubMed - indexed for MEDLINE]
13.

[Clinical thinking and decision making in practice. A young woman with fever, arthralgia and exanthema].

van Meerten E, Berghout A, Hendriks WD, Swaak AJ.

Ned Tijdschr Geneeskd. 2002 Jun 15;146(24):1121-5. Dutch.

PMID:
12092302
[PubMed - indexed for MEDLINE]
14.

Development of an interphase fluorescent in situ hybridization (FISH) test to detect t(8;21) in AML patients.

Hagemeijer A, de Klein A, Wijsman J, van Meerten E, de Greef GE, Sacchi N.

Leukemia. 1998 Jan;12(1):96-101.

PMID:
9436927
[PubMed - indexed for MEDLINE]
15.

Relationship between the exposure to cisplatin, DNA-adduct formation in leucocytes and tumour response in patients with solid tumours.

Schellens JH, Ma J, Planting AS, van der Burg ME, van Meerten E, de Boer-Dennert M, Schmitz PI, Stoter G, Verweij J.

Br J Cancer. 1996 Jun;73(12):1569-75.

PMID:
8664132
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Antineoplastic agents. Drug interactions of clinical significance.

van Meerten E, Verweij J, Schellens JH.

Drug Saf. 1995 Mar;12(3):168-82. Review.

PMID:
7619329
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk